Skip to content
‹ Back to IndustriesSciences

Demystifying DAF Sludge

Have you ever twisted the top on a new bottle of soda to see bubbles appear, seemingly out of nowhere, and rise to the top? Do you remember the sound you heard when you twisted the cap? Odds are you know exactly what I’m talking about. But have you ever wondered exactly what’s going on…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Taylor Bagley · ·
Share
Demystifying DAF Sludge

Key takeaways

01

Have you ever twisted the top on a new bottle of soda to see bubbles appear, seemingly out of nowhere, and rise to the top?

02

Do you remember the sound you heard when you twisted the cap?

03

Odds are you know exactly what I’m talking about.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Have you ever twisted the top on a new bottle of soda to see bubbles appear, seemingly out of nowhere, and rise to the top? Do you remember the sound you heard when you twisted the cap? Odds are you know exactly what I’m talking about.

But have you ever wondered exactly what’s going on inside that bottle? If you’ve spent time around a protein processing plant or have worked at a wastewater treatment facility, you probably know the answer. Let’s take a closer look.

Why Is DAF, or Dissolved Air Flotation, Necessary?

The wastewater profession and its lingo are chock-full of acronyms. One of the best-known for a wastewater operator at a meat processing facility is “DAF,” pronounced “daf” or, sometimes, “D-A-F.” It stands for Dissolved Air Floatation, and it basically works like your soda bottle.

To understand this better, let me back up a little. Inside a poultry processing facility, meat is tossed, turned, tumbled, sliced, diced, washed and cut up. Throughout this process, very small bits of meat, fat and other proteins and fibrous particles are detached. This is the beginning of a long journey for these small particles.

The particles flow to a drain and mingle with other discarded parts of the chicken. Along with these larger chicken parts, like feet, heads, entrails and feathers, the small particles work their way to a screening room. Here, we often find large, rotating screens tasked with recovering valuable proteins, attached fats and feathers. These recovered materials are sent to rendering facilities and typically converted into different kinds of meals to be used as animal feed ingredients. The screens capture particles in the range of two hundredths (0.02) to four hundredths (0.04) of an inch and larger. The particles that pass through the screens then flow to wastewater for further treatment.

While it may sound like this water is a typical wastewater stream at this point, in fact, most conventional aerobic wastewater treatment plants cannot treat this water directly due to its high concentration of solids and nutrients. In most cases, to meet all state and federal discharge limits, additional reductions in loading must be achieved before reaching the wastewater plant’s biological treatment system.

How the DAF Does Its Job

Let’s come back around to the bottle of soda and the DAF. A DAF and its bubbles, like the ones you see rising to the top of your spda, will be just the ticket for cutting the loading to wastewater by 70-90%!

What you are observing when you open that bottle of carbonated drink is a result of a release of pressure built up inside the bottle. At the factory, the liquid was carbonated, meaning that CO2 was dissolved into your drink under pressure. Once you release that pressure, the CO2 starts to form gas bubbles, or, to be more technical, comes out of solution. This is exactly how a DAF works, only it uses ambient air injected directly into a waste stream under pressure to create the dissolved air, which will later be depressurized to reform gas bubbles.

But what is this accomplishing? Good question.

Remember the small bits of proteins and fats that made it through the screens? When pressure is released inside the DAF unit, the dissolved air starts to reform into very small air bubbles. As these bubbles rise to the surface, they attach to the small particles of solids suspended in the water, bringing them together and carrying them to the top. By doing this, the DAF system has removed the small particles that a screen could not.

Cool! What Now?

Now that that we have formed a semi-solid slurry (usually referred to as DAF Sludge or just Sludge), the DAF system scrapes the sludge into a collection hopper or tank, where it is ready for Denali to take over and turn this waste into gold. Not literal gold, of course, but something of value, for sure.

Now you understand that DAF Sludge is simply small bits of proteins, fats and fibrous materials that could not be removed by simple mechanical means. In the next blog, we will continue looking at the journey of these small particles and explain that, while small, they can still achieve greatness!

Until then, the next time you pop the top on your soda, remember there is more to the fizz than just a tingle to the taste buds.

To learn more about Denali’s beneficial use program, visit https://www.denaliwater.com/services/beneficial-use/.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

TB
Taylor Bagley
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Celliaz is betting on one AAV2 vector for an eye disease with 90-plus gene causes

Celliaz is betting on one AAV2 vector for an eye disease with 90-plus gene causes

Andelyn Biosciences will develop and manufacture CLZ002, Celliaz's AAV2 gene therapy for retinitis pigmentosa, through IND-enabling work and a planned Phase 1/2 trial. CLZ002 targets retinal repair, not mutations. Because the disease is linked to more than 90 genes, one manufacturing process could end up serving a broad patient group.

  • 01Retinitis pigmentosa has more than 90 causal genes; CLZ002 aims at a shared retinal repair pathway, so a single AAV2 manufacturing process would serve patients that gene-specific programs would split into many products.
  • 02For a pre-IND sponsor, putting plasmid and viral vector production with one CDMO can mean fewer handoffs, and the questions worth settling early are who owns the process built on a proprietary platform and how it would move if needed.

Nov 14, 2026

Lab Manager survey finds 2027 lab hiring budgets nearly flat while supply budgets grow

Lab Manager survey finds 2027 lab hiring budgets nearly flat while supply budgets grow

Lab hiring budgets for 2027 carry a net outlook of just +2, down from +10, while consumables sit at +30 and raw materials at +31. Labs are paying for supplies and planning capital purchases further ahead. New positions face the toughest scrutiny.

  • 01Labs heading into 2027 expect their reagent budgets to grow and their headcount budgets to stall: consumables carry a net outlook of +30, hiring just +2.
  • 02Lab Manager’s read: if consumables spending stays flat, the lab is probably buying less—because respondents reported rising costs across many supply items, from reagents to shipping.
  • 03Hiring gets treated as a recurring cost, not a one-time purchase; one published example estimates ~$46,000/year for a graduate student and $80,000–$100,000 for a postdoc (with fringe) at one institution. Lab Manager recommends justifying new roles with throughput, turnaround and risk—while separating price from volume in supply-line requests.

Nov 13, 2026

Simtra opens $250 million-plus Bloomington building with three sterile filling lines

Simtra opens $250 million-plus Bloomington building with three sterile filling lines

Simtra BioPharma Solutions opened Building H, a $250 million-plus addition to its Bloomington, Indiana campus, featuring two syringe lines and a vial line with lyophilizers. The CDMO plans to expand from 11 to 18 filling lines by 2027. Extra sites reduce supply risk only when products are qualified at both locations.

  • 01Simtra's network is set to grow from 11 to 18 filling lines across Indiana and Germany by 2027, a published capacity timeline sponsors can plan tech transfers against.
  • 02A second fill site cuts supply risk only after a product has been validated there; for biologics that means process validation, comparability work and regulatory filings first.
  • 03Programs whose real exposure sits in concentrated starting-material supply gain little from added fill-finish redundancy, however well the new lines are built.

Nov 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

TB
Taylor Bagley

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512